Interactions between mefloquine and the anti-fibrotic drug silymarin on Schistosoma mansoni infections in mice.

The present study tests the anti-inflammatory and anti-fibrotic effects of silymarin alone or combined with mefloquine on acute schistosomiasis by evaluating parasitological, histopathological, biochemical and immunological parameters. Male CDI Swiss mice were divided into seven groups, which included healthy controls, mice infected with Schistosoma mansoni or treated with silymarin (140 mg/kg body weight) or mefloquine (400 mg/kg body weight), or mice treated with a combination of both drugs and uninfected mice simply treated with mefloquine or silymarin alone. All mouse groups were sacrificed 8 weeks post-infection (pi) and/or post-treatment. Those infected mice treated with both silymarin and mefloquine showed a significant decrease (P <  0.001) in worm burden, immunoglobulins (IgG and IgM), liver function enzymes and granuloma diameter, with complete eradication of immature and mature eggs. In conclusion, treatment with silymarin combined with mefloquine in murine schistosomiasis was able to reduce granulomatous reactions and hepatic fibrosis. Hence, this combination is a new strategy to be studied as an efficient tool in the treatment of schistosomal liver fibrosis.

In vitro effect of artemether and triclabendazole on adult Fasciola gigantica.

Triclabendazole "Fasinex" is the drug of choice against fasciolosis because of its high efficacy against both mature and immature flukes, however parasite resistance against this drug is increasing. Hence, there is pressing need for new fasciolicidal drugs. In the present study, the in vitro effect of artemether on adult flukes was evaluated using scanning electron microscopy. After 24 h incubation with 10 microg/ml artemether, the tegument of the apical cone appeared to be slightly more swollen than normal. This swelling became so severe and the spines appeared sunken, with their tips protruding from a swollen and blebbed base, on increasing the concentration to 20 microg/ml. With the higher concentration of 30 microg/ml, extensive and severe tegumental swelling occurred in the apical cone region of the flukes. There were many blebs around ventral sucker, a number of which appeared to have burst causing lesion. The tegumental changes occurred following incubation in artemether were comparable with those observed with triclabendazole in its active sulphoxide metabolite form (TCBZ-SX).

In vitro tegumental alterations on adult Fasciola gigantica caused by mefloquine.

Emergence of drug-resistant Fasciola strains has drawn the attention of many authors to alternative drugs. The purpose of this study is to explore the in vitro effect of the antimalarial mefloquine against adult Fasciola gigantica. Light and scanning electron microscopic observations could be used to determine the target of the drug following 6 and 12 h of incubation in medium containing mefloquine at three different concentrations 10, 20 and 30 µg/mL, as morphological changes could be observed. These changes occurred in definite sequences in response to mefloquine, and were consisted of swelling, vacuolization that was later disrupted, leading to desquamation of the tegument, resulting in exposure and disruption of basal lamina and the dislodging of spines. It is concluded that mefloquine presented itself as a drug that might become important in trematode chemotherapy, with the tegument being an important drug target.

Immunomodulatory effect of garlic oil extract on Schistosoma mansoni infected mice.

OBJECTIVE: To assess the effect potency, and the immunomodulatory response of garlic oil extract in enhancing the host's immune system against the disorders caused by Schistosoma mansoni (S. mansoni) in mice at different stages of worm maturation. METHODS: A total of 70 male CD-1 Swiss albino mice were divided into 7 groups. Group I: healthy control. Group II: garlic oil group orally administrating 100 mg garlic oil extract/kg b.wt. 3 d a week for 6 weeks. Group III: infected with S. mansoni cercariae and left untreated for 42 d. Group IV: treated with garlic oil extract from day 1 to day 7 post infection (PI). Group V: treated with garlic oil extract from day 14 till day 21 PI. Group VI: administrating garlic oil extract from day 35 until day 42 PI. Group VII received oil extract from the first day of infection for 42 d. RESULTS: Garlic oil extract showed changes in the parasite tegument with a significant decrease in worm burden, hepatic and intestinal ova count with a decline in granuloma number and diameter. These alterations were accompanied with a reduction in serum TNF α, ICAM-1, IgG and IgM after 7 and 42 d post S. mansoni cercarial infection. CONCLUSIONS: Results obtained confirmed the effect of garlic oil extract on the larval and mature stage of the parasite and in enhancing the host's immune system against the disorders caused by S. mansoni in mice.